Joshua P Havens

Acceptability and Feasibility of a Pharmacist-Led Human Immunodeficiency Virus Pre-Exposure Prophylaxis Program in the Midwestern United States

Joshua P Havens, Kimberly K. Scarsi, Harlan Sayles et al. · Open Forum Infectious Diseases · 2019 · 102 citations · Full text

Public Health, Community Pharmacy, Pharmacy Practice +16

Plasma and intracellular pharmacokinetics of tenofovir in patients switched from tenofovir disoproxil fumarate to tenofovir alafenamide

Anthony T. Podany, Sara H Bares, Joshua P Havens et al. · AIDS · 2018 · 84 citations

Pharmacy, Pharmacokinetics, Pharmacology +11

Midwest pharmacists’ familiarity, experience, and willingness to provide pre-exposure prophylaxis (PrEP) for HIV

Jordan M. Broekhuis, Kimberly K. Scarsi, Harlan Sayles et al. · PLoS ONE · 2018 · 37 citations · Full text

Pharmacy, Community Pharmacy, Pharmacy Practice +15

Plasma and intracellular pharmacokinetics of tenofovir disoproxil fumarate and emtricitabine in transgender women receiving feminizing hormone therapy

Lauren R. Cirrincione, Anthony T. Podany, Joshua P Havens et al. · Journal of Antimicrobial Chemotherapy · 2020 · 26 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Acceptability, Feasibility, and Appropriateness of Implementation of Long-acting Injectable Antiretrovirals: A National Survey of Ryan White Clinics in the United States

Adati Tarfa, Harlan Sayles, Sara H Bares et al. · Open Forum Infectious Diseases · 2023 · 22 citations · Full text

Public Health, Community Health, Public Health Practice +17